Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: a randomized clinical trial

Recent evidence points to a potential therapeutic role for glycyrrhizin(GR) and boswellic acids (BA) in the treatment of COVID-19 but conclusive evidence is lacking. Our aim is to investigate the efficacy of GR + BA versus placebo for the treatment of hospitalized patients with moderate SARS-CoV-2 o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomaa, Adel A., Mohamed, Hamdy S., Abd-ellatief, Rasha B., Gomaa, Mohamed A., Hammam, Doaa S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886861/
https://www.ncbi.nlm.nih.gov/pubmed/35233748
http://dx.doi.org/10.1007/s10787-022-00939-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886861/
https://www.ncbi.nlm.nih.gov/pubmed/35233748
http://dx.doi.org/10.1007/s10787-022-00939-7

Ejemplares similares